High telomerase activity in neutrophils from unstable coronary plaques.
OBJECTIVE
We evaluated telomerase activity in circulating polymorphonuclear neutrophils (PMN) and in PMN isolated from coronary atherosclerotic plaques by a novel approach.


BACKGROUND
Delayed apoptosis of PMN have been demonstrated in unstable angina (UA). These cells have a finite lifespan with low telomerase activity, a polymerase that extends telomeres, structures essential for cell aging. Reactivation of telomerase has been associated with resistance to apoptosis.


METHODS
We studied 20 patients with UA and 6 patients with chronic stable angina (SA), undergoing a percutaneous coronary intervention. Circulating PMN were isolated from venous blood and PMN derived from coronary plaque were isolated from washing medium of angioplasty balloons.


RESULTS
Telomerase activity was higher in coronary plaque PMN of UA patients than in coronary plaque PMN of SA patients (122.7, range 20.5 to 3,696; and 47.7, range 16 to 212.6, respectively, p = 0.001) and higher than in peripheral PMN of SA patients (122.7, range 20.5 to 3,696 vs. 59, range 16.5 to 132.5, p = 0.001). We found a statistically significant difference between venous and coronary plaque PMN telomerase activity in UA patients (z = -2.875; p = 0.004). Among UA patients, a shorter time interval from symptom onset to coronary PMN sampling was the only independent predictor of high telomerase activity in coronary plaque PMN (p < 0.001, R2 = 0.75).


CONCLUSIONS
In UA patients, telomerase activity is high in coronary plaque PMN, while it is low in peripheral PMN. Telomerase reactivation in resident PMN resulting in a prolonged lifespan might play a key role in the early phases of instability.
D000368:Aged; D000787:Angina Pectoris / Q000201:enzymology / Q000628:therapy; D000789:Angina, Unstable / Q000201:enzymology* / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D017209:Apoptosis / Q000502:physiology; D016922:Cellular Senescence; D003324:Coronary Artery Disease / Q000201:enzymology* / Q000628:therapy; D003331:Coronary Vessels / Q000201:enzymology; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology*; D019098:Telomerase / Q000097:blood*; D016615:Telomere / Q000502:physiology
D019098:Telomerase